For over 40 years, Hardy Diagnostics has been at the forefront of providing high-quality microbiology products to laboratories worldwide.
Founded in 1980, Hardy Diagnostics has established itself as a premier manufacturer of microbiology products. Headquartered in Santa Maria, California, the company serves hospitals, universities, industrial laboratories, and reference laboratories across the United States and in numerous international markets.
What began as a small operation with just a handful of products has grown into a comprehensive supplier of thousands of microbiology products. Despite this growth, Hardy Diagnostics remains committed to the founding principles of quality, service, and innovation that initially set the company apart in the microbiology market.
The company takes pride in being a privately-owned American business, allowing it to make decisions focused on customer needs rather than shareholder demands. This independence has enabled Hardy Diagnostics to develop long-term relationships with laboratories and researchers, understanding and addressing their evolving requirements.
Hardy Diagnostics offers an extensive portfolio of products designed to meet the diverse needs of microbiology laboratories. Their product lines encompass everything from basic culture media to advanced diagnostic systems.
Manufactured with rigorous quality control, Hardy's prepared media plates, tubes, and bottles include standard formulations, chromogenic media, and specialty media for identifying specific microorganisms.
A wide variety of dehydrated culture media formulations can be prepared according to specific laboratory requirements, including selective, differential, enriched, and general-purpose media types.
Innovative identification systems including disk-based systems, kit-based solutions, and molecular products for quick and accurate microorganism identification.
Numerous diagnostic kits for various applications, including streptococcal grouping, latex agglutination tests, and specialty kits for specific organisms.
A full line of microbiological stains including Gram stains, acid-fast stains, special stains, and an extensive range of reagents for microbiological testing.
Specimen collection and transport systems designed to maintain organism viability during transport to the laboratory, including swab systems and transport containers.
Quality is the cornerstone of Hardy Diagnostics' operations. The company maintains a comprehensive quality management system that ensures every product meets rigorous standards before reaching the customer.
Hardy Diagnostics operates in full compliance with FDA cGMP regulations and maintains ISO 13485 certification for its quality management system. Each lot of prepared media undergoes extensive quality control testing including sterility testing, performance testing, and pH verification. Dehydrated media batches are tested according to CLSI and USP standards to ensure they support the growth of target organisms while inhibiting non-target organisms.
The company maintains complete traceability from raw materials to finished products. This includes detailed documentation of manufacturing processes, quality control results, and distribution records, ensuring accountability throughout the product lifecycle. Hardy Diagnostics employs a continuous improvement approach to quality management, regularly reviewing processes, analyzing performance data, and implementing enhancements.
What sets Hardy Diagnostics apart is its commitment to testing all prepared media lots with actual clinical isolates, rather than just reference strains. This real-world testing approach ensures that products will perform reliably in actual laboratory settings, not just in ideal conditions.
Hardy Diagnostics maintains an active research and development program focused on advancing microbiological solutions. The company collaborates with academic institutions, clinical laboratories, and industry partners to develop new products and improve existing formulations.
Recent innovations include chromogenic media for faster organism identification, specialized transport media for difficult-to-culture organisms, and user-friendly identification systems that streamline laboratory workflows. These developments reflect the company's commitment to addressing the evolving needs of modern microbiology laboratories.
The Hardy Diagnostics research team regularly contributes to scientific literature and presents findings at professional conferences, ensuring that the company stays at the forefront of microbiological advances and emerging diagnostic requirements. The company's scientists work directly with customers to develop custom solutions for specialized testing needs.
Looking to the future, Hardy Diagnostics continues to invest in research areas such as antimicrobial resistance detection, point-of-care microbiology solutions, and environmentally sustainable product development. By focusing on both product innovation and process improvement, Hardy Diagnostics maintains its position as an industry leader in diagnostic microbiology.
